|
|
|
|
||
Re: NEW POST ON RVX BLOGYou just have to shake your head on this one! Unbelieveable! So RVX and Zenith did multiple financings at giveaway prices, and they are investigating switching to the NASDAQ to gain more accurate valuations? “We are currently in discussions with several pharmaceutical companies regarding possible partnering and codevelopment arrangements, but we are not interested in being acquired. We would not sell the company at this point because we believe Resverlogix is significantly undervalued. (McCaffrey) TLSR: Why do you say Resverlogix is undervalued? DM: Resverlogix is a Canadian company. Canadian companies usually are undervalued; historically, Canadian companies being acquired have earned premiums of 500–800%, while for U.S. counterparts premiums are more often at 30 –40%. The Canadian market is tough. We are investigating switching to the NASDAQ to gain more accurate valuations, but will only do so under the proper conditions.” (McCaffrey) http://www.resverlogix.com/upload/media_element/218/01/donald-mccaffrey-lsr-interview-8-26-15.pdf |
return to message board, top of board |